Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
February 1, 2026
Approximately 5 minutes
Procedure for Requesting Exceptional Use of Non-CE Marked Medical Devices in Belgium
Procedure for Requesting Exceptional Use of Non-CE Marked Medical Devices in Belgium
1. Legal Basis and Scope
FAMHP may grant derogation from conformity assessment procedures under Article 59 of Regulation (EU) 2017/745 (MDR) for medical devices or Article 54 of Regulation (EU) 2017/746 (IVDR) for in vitro diagnostic medical devices. This allows placing on the market or putting into service of specific non-CE marked devices in Belgium when justified in the interest of public health, patient safety, or health. Source: FAMHP Request for Exceptional Use Page https://www.famhp.be/en/humain/produits_de_sante/dispositifs_medicaux/utilisation_exceptionnelle/demande_dutilisation
2. Eligibility Criteria
Requests must be duly justified and demonstrate exceptional circumstances:
- Absence of suitable alternatives (any device, product, or treatment achieving similar purpose).
- Significant expected benefit for diagnosis or treatment compared to available alternatives. Off-label use of CE-marked devices is not covered and no derogation request can be submitted. Source: FAMHP Request for Exceptional Use Page https://www.famhp.be/en/humain/produits_de_sante/dispositifs_medicaux/utilisation_exceptionnelle/demande_dutilisation
3. Eligible Applicants
Applications are limited to:
- The manufacturer.
- Its authorised representative.
- A mandated third party (with proof of mandate via contract). The manufacturer or authorised representative remains responsible for compliance with applicable legislation. Source: FAMHP Request for Exceptional Use Page https://www.famhp.be/en/humain/produits_de_sante/dispositifs_medicaux/utilisation_exceptionnelle/demande_dutilisation
4. Types of Derogation
a) Compassionate Use (Individual Device for Specific Patient)
Form divided into Part 1 (completed by applicant: manufacturer, authorised representative, or mandated third party) and Part 2 (completed by the treating physician).
b) National Derogation
For requests not specific to an individual patient. Source: FAMHP Request for Exceptional Use Page https://www.famhp.be/en/humain/produits_de_sante/dispositifs_medicaux/utilisation_exceptionnelle/demande_dutilisation
5. Required Documents
- Completed application form (specific to type).
- For compassionate use: Part 1 by applicant and Part 2 by physician.
- Proof of mandate if third party applicant.
- Detailed justification demonstrating exceptional circumstances, absence of alternatives, and significant benefit. Source: FAMHP Request for Exceptional Use Page https://www.famhp.be/en/humain/produits_de_sante/dispositifs_medicaux/utilisation_exceptionnelle/demande_dutilisation
6. Submission Process
Submit applications electronically to derogation.meddev@fagg-afmps.be. Forms are available in English:
- Compassionate use form.
- National derogation form. If issues opening forms in browser, save and open with a PDF reader. Source: FAMHP Request for Exceptional Use Page https://www.famhp.be/en/humain/produits_de_sante/dispositifs_medicaux/utilisation_exceptionnelle/demande_dutilisation
7. Important Notes
Derogation authorizes use only in Belgium. No fees or specific processing times are mentioned. Page last updated 06/12/2024. Source: FAMHP Request for Exceptional Use Page https://www.famhp.be/en/humain/produits_de_sante/dispositifs_medicaux/utilisation_exceptionnelle/demande_dutilisation
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Regulatory Requirements for Class I Medical Device Manufacturers in Belgium
Manufacturers of Class I medical devices in Belgium must fully comply with the MDR (EU) 2017/745, register in Eudamed, notify FAMHP during the transition period until May 2026, issue an EU Declaration of Conformity, maintain technical documentation, and fulfil post-market surveillance obligations, with specific rules for sterile, measuring, and reusable surgical subcategories.
Approximately 5 minutes
Regulatory Requirements for Systems and Procedure Packs in Belgium
In Belgium, producers of systems and procedure packs under MDR (EU) 2017/745 must ensure compatibility of combined CE-marked devices, draw up a declaration, register in Eudamed (currently voluntary), and notify FAMHP during the transitional period using dedicated forms, with specific rules for changes and acknowledgements.
Approximately 5 minutes
Overview of In Vitro Diagnostic Medical Devices Regulation in Belgium
The FAMHP oversees in vitro diagnostic medical devices (IVDs) in Belgium under Regulation (EU) 2017/746 (IVDR), applicable since 26 May 2022, with transitional provisions from Directive 98/79/EC and phased Eudamed registration requirements until mandatory in 2026.
Approximately 5 minutes
Application Procedure for Free Sales Certificates in Belgium
In Belgium, Free Sales Certificates (FSCs) for medical devices and IVDs are issued by FAMHP electronically since February 2025, with applications submitted by email using specific forms, a fee of €283.66 per certificate in 2026, limits on devices per certificate, and required supporting documents including conformity declarations and transitional proofs where applicable.